Coverage

Latest commissioned research from ABG Sundal Collier

Eolus Vind - Adjusting estimates for new project accounting

Napatech - Challenging market conditions continued in Q3

Cavotec - Ramp-up kicks off, but lower margins and FCF

Read earlier research

Recent media selection from our coverage

Careium - Company presentation with President & CEO Carl-Johan Zetterberg Boudrie

Xplora Technologies - Company presentation with Founder & CEO Sten Kirkbak and CFO Mikael Clement

DistIT - Company presentation with CEO Robert Rosenzweig

Eurocon - Company presentation with CEO Peter Johansson

Catella - Company presentation with CEO Christoffer Abramson, CFO Mattias Brodin & Head of IR Michel Fischier

New Event

ABGSC Investor Days
Tuesday 6 - Wednesday 7 December 2022

HAYMARKET by Scandic
Hötorget 13-15 Stockholm

Livestreamed at cr.abgsc.com

NO REGISTRATION REQUIRED

Livestream links will go live the day of the event.

CLICK TO VIEW PROGRAMME

CONFIRMED COMPANIES:

Amniotics	KlaraBo
Arise	Nanexa
Aros Bostad	Napatech
Ascelia Pharma	NAXS
Awardit	Neola Medical
Bergman & Beving	Nexam Chemical
Beijer Alma	Nilörngruppen
Bredband2	Norna
BTS Group	OrganoClick
Catella	PION Group
Clavister	Polygiene
ContextVision	Prevas
Copperstone Resources	Pricer
CTT Systems	Proact
Diös Fastigheter	Q-linea
DistIT	Rottneros
Eastnine	SinterCast
Ework Group	Sivers Semiconductors
Fastator	SmartCraft
Fiskars Group	Stenhus Fastigheter
Flexion Mobile	StrongPoint
FM Mattsson Group	Studsvik
G5 Entertainment	Swedish Stirling
Gapwaves	Tethys Oil
GOMspace	XNK Therapeutics
INVISIO

Latest company news

Past Event

ABGSC Investor Day
Wednesday 14 September

The seminar was recorded on 13 September from ABG Sundal Collier's office in Stockholm.

Click below to view company presentations

Ascelia Pharma	Litium
Axactor	Maha Energy
BankNordik	Neola Medical
Bergs Timber	Nordic Waterproofing
Biovica International	OssDsign
Boule Diagnostics	Ovzon
EG7	Penneo
Eltel	Physitrack
Embellence Group	Precise Biometrics
Eolus Vind	Projektengagemang
Eurocon Consulting	Qlosr
Fastpartner	Rovio
FluoGuide	Seafire
Formpipe	Stendörren Fastigheter
Freemelt	Trianon
Guard Therapeutics	Xplora Technologies
Intervacc	Össur
IRLAB Therapeutics

About ABGSC

Enabling businesses and capital to grow and perform ABG Sundal Collier is founded on an inclusive partnership culture and the ability to attract and develop top talent. The merger between Norwegian Sundal Collier and Swedish ABG in 2001 laid the foundation for today’s independent, full-service investment bank. We have a strong Nordic heritage, with operations in Norway, Sweden and Denmark and a global reach through our sales offices in Frankfurt, London, New York and Singapore. Relying on our superior transaction experience and network, we advise and guide clients when acquiring, consolidating or selling assets. With our outstanding investor access and placing power, we help corporations and entrepreneurs to finance their businesses. Through our highquality research, we enable smarter investment decisions. We are committed to excellence, and offer deep sector knowledge, extensive transaction experience and access to a large network of corporates and investors. We take great pride in always delivering first-class service, and we always seek to obtain a high degree of client satisfaction.

Press the button and be introduced to a new random company!

Social media

Latest commissioned research from ABG Sundal Collier

Eolus Vind - Adjusting estimates for new project accounting

Napatech - Challenging market conditions continued in Q3

Cavotec - Ramp-up kicks off, but lower margins and FCF

Recent media selection from our coverage

Q-Free

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

Q-Free

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

Freemelt

Kommuniké från extra bolagsstämma december 2022 i Freemelt Holding AB (publ)

Maha Energy

The board of directors of Maha Energy AB (publ) (“Maha” or the “Company”) announces that it is investigating two potential divestment opportunities

MT Højgaard Holding

MT Højgaard Holding A/S: MT Højgaard Danmark to construct production facility for Novo Nordisk